Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

CYH33

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

HaiHe Biopharma

Drug class:

PIK3CA inhibitor

Related drugs:

PIK3CA mutation	Ovarian Cancer	PIK3CA mutation	Ovarian Cancer	CYH33 Sensitive: C2 – Inclusion Criteria CYH33 Sensitive : C2	CYH33 Sensitive: C2 – Inclusion Criteria CYH33 Sensitive : C2
PIK3CA mutation	Breast Cancer	PIK3CA mutation	Breast Cancer	CYH33 Sensitive: C2 – Inclusion Criteria CYH33 Sensitive : C2	CYH33 Sensitive: C2 – Inclusion Criteria CYH33 Sensitive : C2
PIK3CA E545K	Gastric Cancer	PIK3CA E545K	Gastric Cancer	CYH33 Sensitive: C4 – Case Studies CYH33 Sensitive : C4	CYH33 Sensitive: C4 – Case Studies CYH33 Sensitive : C4
PIK3CA E545K	Breast Cancer	PIK3CA E545K	Breast Cancer	CYH33 Sensitive: C4 – Case Studies CYH33 Sensitive : C4	CYH33 Sensitive: C4 – Case Studies CYH33 Sensitive : C4
PIK3CA E545K	Ovarian Cancer	PIK3CA E545K	Ovarian Cancer	CYH33 Sensitive: C4 – Case Studies CYH33 Sensitive : C4	CYH33 Sensitive: C4 – Case Studies CYH33 Sensitive : C4
PIK3CA E545A	Ovarian Cancer	PIK3CA E545A	Ovarian Cancer	CYH33 Sensitive: C4 – Case Studies CYH33 Sensitive : C4	CYH33 Sensitive: C4 – Case Studies CYH33 Sensitive : C4
PIK3CA E545K	HER2 Negative Breast Cancer	PIK3CA E545K	HER2 Negative Breast Cancer	CYH33 Sensitive: C4 – Case Studies CYH33 Sensitive : C4	CYH33 Sensitive: C4 – Case Studies CYH33 Sensitive : C4
PIK3CA E542K	Gastric Cancer	PIK3CA E542K	Gastric Cancer	CYH33 Resistant: C4 – Case Studies CYH33 Resistant : C4	CYH33 Resistant: C4 – Case Studies CYH33 Resistant : C4